RenaissanceRe (RNR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
15 Jan, 2026Executive summary
Net income available to common shareholders reached $1.17 billion in Q3 2024, up from $194 million in Q3 2023, with operating income at $540 million and annualized ROE of 47.1%.
Book value per share increased 12.5% sequentially to $202.01, and tangible book value per share plus accumulated dividends rose 15%.
Gross premiums written increased 48% year-over-year to $2.4 billion, driven by the Validus acquisition and organic growth.
The Validus acquisition, completed in November 2023, significantly contributed to scale, diversification, and capital efficiency.
Share repurchase authorization increased to $750 million, with $215 million repurchased year-to-date.
Financial highlights
Net premiums earned rose 47% year-over-year to $2.58 billion; underwriting income was $394 million with a combined ratio of 84.8%.
Net investment income increased 29% to $424 million; total investment result was $1.37 billion, including $944 million in mark-to-market gains.
Fee income rose 27% to $82 million, reflecting growth in joint ventures and managed funds.
Diluted EPS was $22.62, up from $3.80 in Q3 2023.
Tangible book value per share plus change in accumulated dividends up 30% since December 2023.
Outlook and guidance
Management expects continued strong demand for reinsurance, especially at higher program layers, and ongoing capital returns to shareholders.
The Validus acquisition is expected to continue providing scale, diversification, and accretive returns.
Hurricane Milton is estimated to have a $275 million net negative impact on Q4 2024 results.
Bermuda to implement a 15% corporate income tax in 2025; accruals to begin in Q1 2025.
Latest events from RenaissanceRe
- Key votes include director elections, executive pay, incentive plan, and auditor appointment.RNR
Proxy Filing18 Mar 2026 - 2025 saw record returns, board refreshment, and enhanced ESG focus, with all proposals recommended for approval.RNR
Proxy Filing18 Mar 2026 - Net income hit $2.65B in 2025, with 30.8% book value growth despite major loss events.RNR
Q4 20254 Feb 2026 - Q2 2024 saw $495M net income, 29% premium growth, and strong returns from Validus.RNR
Q2 20242 Feb 2026 - Record $2.2B operating income and 26% tangible book value growth despite catastrophe losses.RNR
Q4 20249 Jan 2026 - Catastrophe losses led to an operating loss, but investment gains and capital strength persisted.RNR
Q1 202520 Dec 2025 - 2024 saw record growth, strategic integration, and enhanced governance, with all proposals recommended for approval.RNR
Proxy Filing2 Dec 2025 - Key votes include director elections, executive pay, and auditor approval for 2025.RNR
Proxy Filing2 Dec 2025 - Q2 2025 net income rose 67% with a 75.1% combined ratio and strong book value growth.RNR
Q2 20255 Nov 2025